Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

NCT00135005 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals